Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""kaplan-meier estimate"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 623
Tytuł:
Metastasis patterns and prognosis in young gastric cancer patients: A propensity score‑matched SEER database analysis.
Autorzy:
Zhang H; School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, China.; Health Management Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
Cheng X; Clinical Medical Research Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
Guo W; School of Nursing, Ningxia Medical University, Yinchuan, Ningxia, China.
Zheng C; School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Zhang Y; School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, China.
Jing X; School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, China.
Qiao H; School of Public Health and Management, Ningxia Medical University, Yinchuan, Ningxia, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 09; Vol. 19 (4), pp. e0301834. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*
Liver Neoplasms*
Bone Neoplasms*/secondary
Lung Neoplasms*
Adolescent ; Humans ; Adult ; Propensity Score ; SEER Program ; Kaplan-Meier Estimate ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.
Autorzy:
Ali E; Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.
Červenková L; Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.; Department of Pathology, Third Faculty of Medicine, Charles University, Ruská 87, Prague, 10000, Czech Republic.
Pálek R; Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.; Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, Pilsen, 32300, Czech Republic.
Ambrozkiewicz F; Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.
Hošek P; Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.
Daum O; Sikl's Institute of Pathology, Faculty of Medicine and Teaching Hospital in Plzen, Charles University, Edvarda Beneše 13, Pilsen, 30599, Czech Republic.; Bioptická Laboratoř s.r.o, Mikulášské Nám. 4, Pilsen, 32600, Czech Republic.
Liška V; Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.; Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, Pilsen, 32300, Czech Republic.
Hemminki K; Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic.; Department of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Trailin A; Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, Pilsen, 32300, Czech Republic. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 29; Vol. 24 (1), pp. 142. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Prognosis ; Mast Cells/pathology ; Kaplan-Meier Estimate ; Macrophages/pathology ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population-based study in patients with breast cancer.
Autorzy:
Chai Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen Y; Department of Plastic Surgery, Peking University Third Hospital, Beijing, China.
Liu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
He M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Sep; Vol. 14 (27), pp. 2793-2803. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/diagnosis
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Humans ; Female ; Neoplasm Staging ; Kaplan-Meier Estimate ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real-world experience.
Autorzy:
Lin PT; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University.
Hung MH; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Shao SC; Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chen HY; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chan YY; Department of Pharmaceutical Materials Management, Chang Gung Medical Foundation, Taoyuan, Taiwan.
Chang KC; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin SM; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Ou HT; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan.; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 14902-14911. Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Male ; Middle Aged ; Aged ; Female ; Retrospective Studies ; alpha-Fetoproteins/analysis ; Kaplan-Meier Estimate ; Treatment Outcome ; Ramucirumab
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs.
Autorzy:
Wu T; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China.
Li N; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China.
Luo F; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China.
Chen Z; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China.
Ma L; School of Public Health and Health Management, Gannan Medical University, Ganzhou, 341000, China.
Hu T; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China.
Hong G; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China. .
Li H; School of Medical Information Engineering, Gannan Medical University, Ganzhou, 341000, China. biomantis_.
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2023 Apr 29; Vol. 24 (1), pp. 176. Date of Electronic Publication: 2023 Apr 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Liver Neoplasms*/pathology
MicroRNAs*/genetics
Humans ; Prognosis ; Pyroptosis ; Kaplan-Meier Estimate ; RNA, Messenger/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma.
Autorzy:
Zeng H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, No.25 Taiping Street, Luzhou, Sichuan Province, China.
Su K; Department of Oncology, The Affiliated Hospital of Southwest Medical University, No.25 Taiping Street, Luzhou, Sichuan Province, China.
Chen X; Department of Oncology, The Affiliated Hospital of Southwest Medical University, No.25 Taiping Street, Luzhou, Sichuan Province, China.
Li X; Department of Oncology, 363 Hospital, Chengdu, China.
Wen L; Department of Geriatric Cardiology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China.
Song Y; Department of Radiotherapy, School of Medicine, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Chen L; Department of Oncology and Hematology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, China.
Li H; Department of Oncology, The Affiliated Hospital of Southwest Medical University, No.25 Taiping Street, Luzhou, Sichuan Province, China.
Guo L; Department of Ophthalmology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Han Y; Department of Oncology, The Affiliated Hospital of Southwest Medical University, No.25 Taiping Street, Luzhou, Sichuan Province, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Apr 27; Vol. 13 (1), pp. 6879. Date of Electronic Publication: 2023 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Retrospective Studies ; Propensity Score ; Treatment Outcome ; Kaplan-Meier Estimate ; SEER Program
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Significance of TUBGCP4 Expression in Hepatocellular Carcinoma.
Autorzy:
Zheng C; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Zhang J; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Jiang F; Guilin Center for Disease Control and Prevention, Guilin, 541001 Guangxi, China.
Li D; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Huang C; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Guo X; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Zhu X; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.
Tan S; Department of Epidemiology and Health Statistics, School of Public Health, Guilin Medical University, Guilin, 541199 Guangxi, China.; Department of Epidemiology and Health Statistics, School of Public Health, Central South University, Changsha 410005, China.
Pokaż więcej
Źródło:
Analytical cellular pathology (Amsterdam) [Anal Cell Pathol (Amst)] 2022 Dec 08; Vol. 2022, pp. 9307468. Date of Electronic Publication: 2022 Dec 08 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; Clinical Relevance ; Kaplan-Meier Estimate ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; RNA, Messenger ; Microtubule-Associated Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma.
Autorzy:
Chen F; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, People's Republic of China.; Department of Nursing, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, People's Republic of China.
Wu Y; Department of Nursing, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, People's Republic of China.
Xu H; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, People's Republic of China.
Song T; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, Zhejiang, People's Republic of China.
Yan S; Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 19; Vol. 12 (1), pp. 19923. Date of Electronic Publication: 2022 Nov 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; SEER Program ; Kaplan-Meier Estimate ; Marital Status
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
Autorzy:
Li R; Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Jin C; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Zhao W; Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Liang R; Biological Engineering Academy, Chongqing University, Chongqing, China.
Xiong H; Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2022 Nov 07; Vol. 22 (1), pp. 450. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
RNA, Long Noncoding*/genetics
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Humans ; Prognosis ; Gene Expression Regulation, Neoplastic ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/analysis ; Kaplan-Meier Estimate ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma.
Autorzy:
Wang B; Department of Hepatobiliary Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, 322100, Zhejiang, People's Republic of China.
Fu J; Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, Zhejiang, People's Republic of China.; Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou, 310015, Zhejiang, People's Republic of China.
Lin Y; Department of Research, Hangzhou MC Life Sciences Co., Ltd, Hangzhou, 311500, Zhejiang, People's Republic of China.
Lou Y; Department of Occupational Medicine, Zhejiang Provincial Integrated Chinese and Western Medicine Hospital, Hangzhou, 310003, People's Republic of China.
Lu A; Department of Hepatobiliary Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, 322100, Zhejiang, People's Republic of China.; Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, Zhejiang, People's Republic of China.
Yang J; Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, Zhejiang, People's Republic of China. .; Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou, 310015, Zhejiang, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 27; Vol. 12 (1), pp. 18066. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Humans ; Biomarkers, Tumor/genetics ; Kaplan-Meier Estimate ; Prognosis ; Tumor Microenvironment/genetics ; Autophagy-Related Proteins/genetics ; Vesicular Transport Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2.
Autorzy:
Ye F; Ultrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Le H; First Surgical Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
He F; Ultrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Tu H; Ultrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Peng D; First Surgical Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Ruan S; Ultrasound Imaging Department I, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Sep 29; Vol. 2022, pp. 7356297. Date of Electronic Publication: 2022 Sep 29 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
ADAM Proteins ; Adaptor Proteins, Signal Transducing/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Humans ; Integrins/genetics ; Integrins/metabolism ; Kaplan-Meier Estimate ; LIM Domain Proteins ; Membrane Proteins/genetics ; Prognosis ; Retrospective Studies ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Construction of a Novel Oxidative Stress Response-Related Gene Signature for Predicting the Prognosis and Therapeutic Responses in Hepatocellular Carcinoma.
Autorzy:
Hong J; Key Laboratory of Laparoscopic Technique Research of Zhejiang Province, Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Cai X; Key Laboratory of Laparoscopic Technique Research of Zhejiang Province, Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Sep 12; Vol. 2022, pp. 6201987. Date of Electronic Publication: 2022 Sep 12 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Immune Checkpoint Inhibitors ; Kaplan-Meier Estimate ; Oxidative Stress ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma.
Autorzy:
Zhou Y; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhou X; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Liu Q; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang W; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Ma J; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang M; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yu J; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Luo J; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Yan Z; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institution of Medical Imaging, Shanghai, China.; National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Sep 12; Vol. 2022, pp. 8973721. Date of Electronic Publication: 2022 Sep 12 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Liver Neoplasms*/therapy
Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
Autorzy:
Chen W; Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.; Department of General Surgery, Air Force Hospital of Western Theater Command, Chengdu 610021, China.
Yang Z; Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
Chen Y; Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Sep 05; Vol. 2022, pp. 3594901. Date of Electronic Publication: 2022 Sep 05 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Humans ; Kaplan-Meier Estimate ; Oxidative Phosphorylation ; Prognosis ; Prospective Studies ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer.
Autorzy:
Cheng Z; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No. 1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.; Key Clinical Laboratory of Henan Province, NO.1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.
Guo Y; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No. 1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.; Key Clinical Laboratory of Henan Province, NO.1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.
Sun J; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No. 1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.; Key Clinical Laboratory of Henan Province, NO.1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052.
Zheng L; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No. 1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052. .; Key Clinical Laboratory of Henan Province, NO.1 Jian She East Road, Zhengzhou, Henan, People's Republic of China, 450052. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Aug 22; Vol. 12 (1), pp. 14261. Date of Electronic Publication: 2022 Aug 22.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Biomarkers, Tumor/genetics ; DNA Copy Number Variations ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma.
Autorzy:
Chen B; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, No.2 fuxue lane, Wenzhou, 325000, Zhejiang, People's Republic of China.
Yang Z; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Lang Z; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Tao Q; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhang R; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhan Y; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Xu X; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhu K; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zheng J; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Yu Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, No.2 fuxue lane, Wenzhou, 325000, Zhejiang, People's Republic of China. .
Yu S; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, No.2 fuxue lane, Wenzhou, 325000, Zhejiang, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Aug 09; Vol. 22 (1), pp. 867. Date of Electronic Publication: 2022 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Leukemia, Erythroblastic, Acute*
Liver Neoplasms*/pathology
RNA, Long Noncoding*/metabolism
Biomarkers, Tumor/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Autorzy:
Ni HH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.
Yang XH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.; Department of Gastrointestinal Surgical Oncology, Chenzhou No. 1 People's Hospital, Chenzhou, 423000 Hunan, China.
Yang CL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.
Zhang Q; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.
Xu JX; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.
Qi LN; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Xiang BD; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Key Laboratory of Early Prevention and Treatment for Regional High-Frequency Tumors, Ministry of Education, Nanning, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Jul 16; Vol. 2022, pp. 7305953. Date of Electronic Publication: 2022 Jul 16 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Neoplastic Cells, Circulating*
Hepatectomy ; Humans ; Kaplan-Meier Estimate ; Lymphocyte Count ; Lymphocytes/pathology ; Neutrophils/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma.
Autorzy:
Liu X; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Xiao C; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Yue K; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Chen M; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Zhou H; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. .
Yan X; Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 15; Vol. 12 (1), pp. 12084. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
RNA, Long Noncoding*/genetics
Biomarkers, Tumor/genetics ; Carcinogenesis/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis ; RNA, Messenger/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma.
Autorzy:
Yang L; Department of Hepatobiliary, Pancreatic and Splenic Surgery, People's Hospital of Luzhou City, Luzhou, China.
Zeng LF; Department of Hepatobiliary, Pancreatic and Splenic Surgery, People's Hospital of Luzhou City, Luzhou, China.
Hong GQ; Department of Hepatobiliary Surgery, Tongnan District People's Hospital, Chongqing, China.
Luo Q; Department of Hepatobiliary Surgery, Tongnan District People's Hospital, Chongqing, China.
Lai X; Department of Hepatobiliary Surgery, Tongnan District People's Hospital, Chongqing, China.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2022 Jul 12; Vol. 2022, pp. 6535009. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Immunity ; Kaplan-Meier Estimate ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bioinformatics Analysis for Constructing a Six-Immune-Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular Carcinoma.
Autorzy:
Wang J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Jin Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Wu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Wang J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Xu B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Zhu H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Guo Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Wen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Province, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 Jul 07; Vol. 2022, pp. 2093437. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
RNA, Long Noncoding*/genetics
Biomarkers, Tumor/genetics ; Computational Biology ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 623

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies